Figure 3. SUMF1 overexpression is significantly correlated with poor survival time in subgroups of glioma. (A) IDH mutant patients; (B) Patients with the non-codel in 1p/19q codeletion; (C) Patients with the codel in 1p/19q codeletion; (D) Female; (E) Male; (F) Age ≤60; (G) Age >60; (H) Astrocytoma; (I) Oligodendroglioma.